Comcon Pharma Consulting Private Limited

Comcon Pharma Consulting Private Limited - real estate in New Delhi, Delhi, India. Directors, charges & compliance details.
CIN U70200DL2024PTC434974 Incorporated 02 August 2024 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company real estate
Data last updated
Revenue · FY 2025
₹2.15 Lakh
Latest filing
Net profit · FY 2025
₹1.34 Lakh
Net margin 62.3%
EBITDA · FY 2025
₹1.79 Lakh
EBITDA margin 83.3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
2 yrs
Est. 2024
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Comcon Pharma Consulting Private Limited

Data last updated:

Comcon Pharma Consulting Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the real estate leasing and property management segment of the real estate sector. It was incorporated on 02 August 2024.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U70200DL2024PTC434974.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Oleksii Sukhomlynov and Prasoon Paliwal.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 44 Backary Portion, 2nd Floor Regal Building, New Delhi, Delhi, India – 110001.

As per the financials filed for FY 2025, the company reported a revenue of ₹2.15 Lakh. For the same year it recorded a net profit of ₹1.34 Lakh (net margin 62.3%) and EBITDA of ₹1.79 Lakh (EBITDA margin 83.3%).

Company Details of Comcon Pharma Consulting Private Limited
CIN U70200DL2024PTC434974
Registration Number 434974
Incorporation Date 02 August 2024
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    44 Backary Portion, 2nd Floor Regal Building, New Delhi, Delhi, India – 110001
  • Industry
    Real Estate, Real Estate Leasing, Contractual Work
Comprehensive company report
Comcon Pharma Consulting Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Comcon Pharma Consulting Private Limited report

Financials, compliance, directors, charges, ownership and filings for Comcon Pharma Consulting Private Limited in one report.

Financials from FY 2025 Directors & ownership Charges & compliance

Financials of Comcon Pharma Consulting Private Limited FY 2025 filings available

Comcon Pharma Consulting Private Limited reported revenue of ₹2.15 Lakh for FY 2025.

Revenue · FY 2025
₹2.15 Lakh
Net profit · FY 2025
₹1.34 Lakh margin 62.3%
EBITDA · FY 2025
₹1.79 Lakh margin 83.3%

Financial Statement Summary of Comcon Pharma Consulting Private Limited

MetricsFY 2024-25
Profit and Loss Statement
Revenue from Operations••••
Other Income••••
Total Revenue••••
Cost of Materials Consumed••••
Employee Benefit Expense••••
Finance Costs••••
Depreciation and Amortisation••••
Other Expenses••••
Total Expenses••••
EBITDA₹1.79 Lakh
Profit Before Tax••••
Tax Expense••••
Net Profit (PAT)₹1.34 Lakh
Balance Sheet
Share Capital••••
Reserves and Surplus••••
Net Worth (Total Equity)••••
Long-term Borrowings••••
Short-term Borrowings••••
Trade Payables••••
Total Liabilities••••
Fixed Assets••••
Investments••••
Inventories••••
Trade Receivables••••
Cash and Bank Balance••••
Total Assets••••

Financial Ratios of Comcon Pharma Consulting Private Limited

MetricsFY 2024-25
Profitability
EBITDA Margin83.3%
Net Profit Margin62.3%
Return on Equity (ROE)••••
Return on Capital Employed (ROCE)••••
Return on Assets (ROA)••••
Liquidity and Debt
Current Ratio••••
Quick Ratio••••
Debt-to-Equity Ratio••••
Interest Coverage Ratio••••
Efficiency and Growth
Asset Turnover••••
Receivable Days••••
Payable Days••••
Inventory Days••••
Revenue Growth••••
Net Profit Growth••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Comcon Pharma Consulting are in the company report.

Premium access

Financial statements from FY 2025

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Comcon Pharma Consulting Private Limited

Comcon Pharma Consulting Private Limited is compared with the companies closest to it by revenue in the Outsourcing industry (Consulting Services). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Admire Commodities Private Limited₹2.16 Lakh (FY 2025)••••••••-5.0%••••Kolkata, West Bengal, India
Shalimar Tie-Up Private Limited₹2.16 Lakh (FY 2025)••••••••-5.0%••••Kolkata, West Bengal, India
Prismer Business Solutions Private Limited₹2.15 Lakh (FY 2024)••••••••-77.0%••••Chennai, Tamil Nadu, India
Engrow Solutions Private Limited₹2.15 Lakh (FY 2024)••••••••33.0%••••Ranchi, Jharkhand, India
CHPL Consultants Private Limited₹2.15 Lakh (FY 2025)••••••••-96.0%••••Hyderabad, Telangana, India
Comcon Pharma Consulting Private Limited this company₹2.15 Lakh (FY 2025)••••••••••••New Delhi, Delhi, India
Kanak Dealers Private Limited₹2.15 Lakh (FY 2025)••••••••139.0%••••Kolkata, West Bengal, India
Florem Multiventures Private Limited₹2.15 Lakh (FY 2025)••••••••122.0%••••Navi Mumbai, Maharashtra, India
Sidcom Analytics Private Limited₹2.15 Lakh (FY 2025)••••••••537.0%••••Indore, Madhya Pradesh, India
Elite Kaisha Consulting Private Limited₹2.14 Lakh (FY 2025)••••••••-47.0%••••New Delhi, Delhi, India
Hii Labs Private Limited₹2.14 Lakh (FY 2025)••••••••-74.0%••••Pune, Maharashtra, India

Peers are the five companies nearest above and the five nearest below Comcon Pharma Consulting by revenue in the Outsourcing industry (Consulting Services), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Board of Directors of Comcon Pharma Consulting Private Limited

Comcon Pharma Consulting has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Oleksii SukhomlynovDirector02 Aug 20242 Years 2 MonthsCurrent
Prasoon PaliwalDirector02 Aug 20242 Years 2 MonthsCurrent

Charges & Borrowings of Comcon Pharma Consulting Private Limited

Comcon Pharma Consulting Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Comcon Pharma Consulting Private Limited

Employment history and EPFO contributions of people linked to Comcon Pharma Consulting.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Comcon Pharma Consulting Private Limited

Comcon Pharma Consulting Private Limited has 3 board changes on record since 2024: 2 appointments and 1 cessation. The latest: Gaurav Sharma ceased to be Director on 11 Nov 2024.

AGM
Comcon Pharma Consulting Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Comcon Pharma Consulting Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Gaurav Sharma ceased to be Director.
Appointed
Oleksii Sukhomlynov was appointed as Director.
Appointed
Prasoon Paliwal was appointed as Director.
Incorporation
02 Aug 2024
Comcon Pharma Consulting Private Limited was registered on 02 Aug 2024 with Roc Delhi & aged 2 years 2 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Comcon Pharma Consulting Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Comcon Pharma Consulting Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Comcon Pharma Consulting Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Comcon Pharma Consulting Private Limited

Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Comcon Pharma Consulting Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Comcon Pharma Consulting Private Limited

Comcon Pharma Consulting is an active private limited company based in New Delhi, Delhi, India. The company works in real estate leasing, within the real estate industry. It was incorporated on 02 August 2024 (2+ years old) and is registered under CIN U70200DL2024PTC434974.

Comcon Pharma Consulting reported revenue of ₹2.15 Lakh for FY 2025.

Comcon Pharma Consulting has 2 current directors:

Comcon Pharma Consulting reported a net profit of ₹1.34 Lakh (net margin 62.3%) and EBITDA of ₹1.79 Lakh (EBITDA margin 83.3%) for FY 2025, as per its filed financial statements.

The CIN (Corporate Identification Number) of Comcon Pharma Consulting is U70200DL2024PTC434974. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Comcon Pharma Consulting was incorporated on 02 August 2024, making it 2+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Comcon Pharma Consulting by revenue are Admire Commodities Private Limited, Shalimar Tie-Up Private Limited, Prismer Business Solutions Private Limited, Engrow Solutions Private Limited, CHPL Consultants Private Limited and 5 more, all in the Outsourcing industry (Consulting Services).

Gaurav Sharma ceased to be Director on 11 Nov 2024. Oleksii Sukhomlynov was appointed as Director on 02 Aug 2024. Prasoon Paliwal was appointed as Director on 02 Aug 2024.

The registered office of Comcon Pharma Consulting is at 44 Backary Portion, 2nd Floor Regal Building, New Delhi, Delhi, India – 110001.

Comcon Pharma Consulting has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.

Comcon Pharma Consulting operates in the real estate industry, in the real estate leasing segment.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available